Save the Children Global Ventures

Save the Children Global Ventures is the impact-investing arm of Save the Children, deploying patient capital into early-stage companies whose products improve outcomes for children, particularly in health, education, and child protection. The structure is closer to mission-driven impact investment than commercial venture, and founders should treat it as a patient-capital partner rather than a financial-return optimizer. Stage focus is typically seed through Series A, with checks in the $250k to $2M range and a longer-than-typical hold horizon. Healthcare exposure is concentrated in pediatric health, maternal and newborn care, child mental health, and global health innovations targeting low- and middle-income markets. Physician founders building pediatric digital health, global health innovations, or mental health products specifically targeting children and families are the natural fit. Founders building adult-focused therapeutics, devices unrelated to children’s health, or commercial-only software without an impact thesis should pitch elsewhere. Geographic posture is global, with active interest in low- and middle-income market deals. The realistic entry path is engagement through the firm’s published process or via a warm introduction from an impact ecosystem operator or an existing portfolio founder. Founders should arrive with a credible theory of change, real outcome data, and a defended commercial sustainability plan. Treat Save the Children Global Ventures as a mission-aligned patient-capital partner, complementary to a commercial lead.